Preoperative vs. Pathologic Size in Breast Cancer: A Prospective Study
Recruiting · NCT06505577 · Observational (researchers observe without assigning treatment) · Lead sponsor: Incheon St.Mary's Hospital
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
Breast cancer, the most prevalent malignancy among women globally, is increasing in incidence. While non-metastatic breast cancer requires surgery, determining the optimal extent of resection remains challenging. Inadequate resection margins necessitate reoperation, leading to increased psychological stress, costs, and potentially compromised cosmetic outcomes and prognosis. Accurate preoperative assessment of resection extent is crucial and involves various factors, including imaging studies, physical examinations, tumor molecular subtypes, and intraductal carcinoma components. This prospective observational study aims to identify and integrate multiple predictive factors to enhance surgical planning and minimize reoperation rates in breast cancer patients.
Who can take part
Inclusion criteria
- Adult patients (≥ 19 years old) diagnosed with breast cancer (invasive and in situ).
- Patients scheduled for surgical resection of the tumor Availability of both preoperative tumor size assessments and pathologic measurements post-surgery
Exclusion criteria
- Patients with recurrent breast cancer Inflammatory breast cancer Patients who did not undergo surgery Patients whose preoperative tumor size data is not available or deficient for analyzing
Where it is running
1 location listed.
- Incheon St. Mary's Hospital - Incheon, South Korea